This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Herrick, Feinstein Congratulates Mediware Information Systems On Successful Sale To Thoma Bravo, LLC

Herrick, Feinstein LLP congratulates its client, Mediware Information Systems, Inc. ( MEDW), a premier provider of clinical software solutions, on the successful completion of its merger with leading private equity investment firm Thoma Bravo, LLC. The transaction, which was approved by shareholders, is valued at approximately $195 million.

“The approval by shareholders brings this acquisition to a successful conclusion, joining Mediware with Thoma Bravo and enabling the company to build on its exceptional brand and reputation to expand its reach while continuing its record of excellent customer service,” said Irwin A. Kishner, Chairman of Herrick's Executive Committee and Co-Chairman of the firm's Corporate Department.

The Herrick deal team was led by Mr. Kishner and included Partners Stephen E. Fox as well as Counsel Fred Green (benefits) and Sung Hwang (tax) and Associate Liliana Chang.

Herrick’s Corporate Department has a track record of successes representing major clients across the country and around the world, including many Fortune 1000 firms. The firm’s clients include financial institutions, private equity firms, venture capital firms, hedge funds, investment banks and private investors on a full range of matters.

Founded in 1928, Herrick, Feinstein LLP is a prominent 170-lawyer firm providing a full range of legal services, including real estate, litigation, bankruptcy, employment, corporate, tax and personal planning, government relations, insurance and intellectual property law.

Copyright Business Wire 2010

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 17,730.11 -27.80 -0.16%
S&P 500 2,076.78 -0.64 -0.03%
NASDAQ 5,009.2140 -3.9090 -0.08%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs